日本出生队列:婴幼儿流感疫苗接种的有效性不受既往感染史影响
基于日本环境与儿童研究出生队列中≤89253名6月龄至3岁儿童的数据,采用泊松回归调整相对危险度(RR),评估疫苗接种与既往感染对新生流感感染的影响。结果显示1.5-3岁接种疫苗的风险降低(1-RR)为21%-31%,既往感染后新感染RR为2.58-19.3,且无论有无年长同胞、是否入托或既往感染,接种均带来获益。
要点
- 1.5-3岁儿童接种流感疫苗可降低新感染风险21%-31%。
- 有既往流感感染史的1-3岁儿童新感染风险显著升高(RR 2.58-19.3)。
- 分层分析显示接种疫苗仍可降低RR 22%-40%,包括既往感染后接种的3岁儿童(1-RR 21%)。
核心结论
- 无论有无年长同胞、是否入托或既往流感感染史,婴幼儿接种流感疫苗均可获益。
研究设计与样本
- 基于日本环境与儿童研究出生队列,纳入≤89253名6月龄至3岁儿童,采用泊松回归计算调整相对危险度(RR)。
主要发现
- 1.5-3岁接种疫苗的风险降低(1-RR)为21%-31%。
- 既往感染后新感染RR为2.58-19.3(1-3岁)。
- 按至少一个年长同胞和/或入托分层,接种疫苗降低RR 22%-40%。
- 既往感染后接种的3岁儿童新感染1-RR为21%。
- 以上结果均具有统计学显著性。
临床怎么用
- 建议对6月龄至3岁婴幼儿常规接种流感疫苗,即使有既往感染史或入托、有年长同胞也应接种。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We calculated the Poisson-regression-adjusted relative risk (RR) of new influenza infection by vaccination, prior infection, and vaccination after prior infection in a large Japanese birth cohort, using data from ≤89,253 children aged 6 months to 3 years. The effectiveness of risk reduction (1 - RR) by vaccination at ages 1.5-3 years was 21%-31%. The RR of new infection after prior infection vs. no prior infection was 2.58-19.3 at age 1-3 years. An analysis of the 1 - RR data stratified by having at least one senior sibling and/or attending nursery school revealed that vaccination reduced the RR by 22%-40%. The 1 - RR of new infection was 21% in 3-year-old children who were vaccinated after prior infection. All these findings are statistically significant. The results consistently indicate that, regardless of having at least one senior sibling, attending nursery school, and/or being previously infected with influenza, infants and toddlers will benefit from influenza vaccination.
引用
- Yokomichi H, Kojima R, Horiuchi S, et al. Effectiveness of influenza vaccination in infants and toddlers with and without prior infection history: The Japan Environment and Children's Study. Vaccine. 2021. PMID: 33685777. doi:10.1016/j.vaccine.2021.02.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。